Editorial: Revolutionizing cancer care: the promise of liquid biopsy assays for healthcare equity.

Front Oncol

Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, United States.

Published: October 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527784PMC
http://dx.doi.org/10.3389/fonc.2024.1493833DOI Listing

Publication Analysis

Top Keywords

editorial revolutionizing
4
revolutionizing cancer
4
cancer care
4
care promise
4
promise liquid
4
liquid biopsy
4
biopsy assays
4
assays healthcare
4
healthcare equity
4
editorial
1

Similar Publications

Bioprospecting of Natural Products from Medicinal Plants.

Plants (Basel)

December 2024

Centre of Marine Sciences (CCMAR/CIMAR LA), Faculty of Sciences and Technology, University of Algarve, Ed. 7, Campus of Gambelas, 8005-139 Faro, Portugal.

The exploration of natural products derived from medicinal plants that provide an abundance of bioactive compounds has long been a cornerstone of scientific discovery, revolutionizing fields such as medicine, agriculture, and biotechnology [...

View Article and Find Full Text PDF

Revolutionizing Medical Education: ChatGPT3.5 Ability to Behave as a Virtual Patient.

Med Sci Educ

December 2024

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510 USA.

Unlabelled: ChatGPT3.5 is a promising tool for medical education. It provides an affordable, accessible platform for medical students to practice their clinical skills across various medical scenarios.

View Article and Find Full Text PDF

Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis.

Front Cell Neurosci

December 2024

Department of Clinical Neurosciences and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.

Multiple sclerosis (MS), a debilitating autoimmune disorder targeting the central nervous system (CNS), is marked by relentless demyelination and inflammation. Clinically, it presents in three distinct forms: relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and secondary progressive MS (SPMS). While disease-modifying therapies (DMTs) offer some relief to people with RRMS, treatment options for progressive MS (pMS) remain frustratingly inadequate.

View Article and Find Full Text PDF

The intersection between metabolic-associated steatotic liver disease (MASLD) and chronic hepatitis B virus (HBV) infection is an emerging area of research with significant implications for public health and clinical practice. Wang 's study highlights the complexities of managing patients with concurrent MASLD and HBV. The findings revealed that patients with concurrent MASLD-HBV exhibited more severe liver inflammation and fibrosis, whereas those with HBV alone presented a better lipid profile.

View Article and Find Full Text PDF

Intestinal organoids: The path towards clinical application.

Eur J Cell Biol

December 2024

Department of Gastroenterology and Hepatology, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. Electronic address:

Organoids have revolutionized the whole field of biology with their ability to model complex three-dimensional human organs in vitro. Intestinal organoids were especially consequential as the first successful long-term culture of intestinal stem cells, which raised hopes for translational medical applications. Despite significant contributions to basic research, challenges remain to develop intestinal organoids into clinical tools for diagnosis, prognosis, and therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!